UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin

International journal of cancer, 2002-11, Vol.102 (1), p.75-85

2002

Volltextzugriff (PDF)

Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer

Clinical cancer research, 2003-02, Vol.9 (2), p.571-579

2003

Volltextzugriff (PDF)

The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1

The Journal of cell biology, 1998-08, Vol.142 (3), p.873-881

1998

Volltextzugriff (PDF)

Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin

Clinical cancer research, 2006-04, Vol.12 (8), p.2575-2582

2006

Volltextzugriff (PDF)

Differentiation between High- and Low-Grade Astrocytoma Using a Human Recombinant Antibody to the Extra Domain-B of Fibronectin

The American journal of pathology, 2002-11, Vol.161 (5), p.1695-1700

2002

Volltextzugriff (PDF)

Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8

PloS one, 2010-02, Vol.5 (2), p.e9145-e9145

2010

Volltextzugriff (PDF)

Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report

BMC biotechnology, 2011-11, Vol.11 (1), p.104-104, Article 104

2011

Volltextzugriff (PDF)

Use of Uteroglobin for the Engineering of Polyvalent, Polyspecific Fusion Proteins

The Journal of biological chemistry, 2009-09, Vol.284 (39), p.26646-26654

2009

Volltextzugriff (PDF)

Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody

The American journal of pathology, 1999-05, Vol.154 (5), p.1345-1352

1999

Volltextzugriff (PDF)

Age, origin and geodynamic significance of plagiogranites in lherzolites and gabbros of the Piedmont-Ligurian ocean basin

Earth and planetary science letters, 1996-05, Vol.140 (1-4), p.227-241

1996

Volltextzugriff (PDF)

mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma

The Journal of pathology, 2004-07, Vol.203 (3), p.771-779

2004

Volltextzugriff (PDF)

Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder

Journal of cancer research and clinical oncology, 2006-08, Vol.132 (8), p.537-546

2006

Volltextzugriff (PDF)

A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature in vivo

International journal of cancer, 2008-06, Vol.122 (11), p.2405-2413

2008

Volltextzugriff (PDF)

Identification of a novel cell binding site of periostin involved in tumour growth

European journal of cancer (1990), 2011-09, Vol.47 (14), p.2221-2229

2011

Volltextzugriff (PDF)

Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma

The Journal of pathology, 1999-12, Vol.189 (4), p.475-480

1999

Volltextzugriff (PDF)

Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues

International journal of cancer, 1992-11, Vol.52 (5), p.688-692

1992

Volltextzugriff (PDF)

Therapy‐induced antitumor vaccination in neuroblastomas by the combined targeting of IL‐2 and TNFα

International journal of cancer, 2010-07, Vol.127 (1), p.101-110

2010

Volltextzugriff (PDF)

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

Blood, 2002-03, Vol.99 (5), p.1659-1665

2002

Volltextzugriff (PDF)

Selective targeted delivery of TNFα to tumor blood vessels

Blood, 2003-12, Vol.102 (13), p.4384-4392

2003

Volltextzugriff (PDF)

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor α

Cancer research (Chicago, Ill.), 2003-06, Vol.63 (12), p.3202-3210

2003

Volltextzugriff (PDF)

The Alternative Splicing Pattern of the Tenascin-C Pre-mRNA Is Controlled by the Extracellular pH (∗)

The Journal of biological chemistry, 1995-03, Vol.270 (11), p.6243-6245

1995

Volltextzugriff (PDF)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels

Retrovirology, 2006-12, Vol.3 (S1), p.P1-P1, Article P1

2006

Volltextzugriff (PDF)

Vandetanib Improves Anti-Tumor Effects of L19mTNFα in Xenograft Models of Esophageal Cancer

Clinical cancer research, 2011-02, Vol.17 (3), p.447-458

2011

Volltextzugriff (PDF)

A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis‐associated extra type III domain B

International journal of cancer, 2009-08, Vol.125 (4), p.751-758

2009

Volltextzugriff (PDF)

comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies

Histochemistry and cell biology, 2010-04, Vol.133 (4), p.467-475

2010

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(99)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(56)
Humans
(52)
Biological And Medical Sciences
(39)
Medical Sciences
(27)
Animals
(24)
Oncology
(24)
Mice
(20)
Tumors
(20)
Fibronectins - Immunology
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Cell Biology
(12)
Fibronectin
(12)
Immunohistochemistry
(12)
Biochemistry & Molecular Biology
(11)
Fibronectins - Genetics
(11)
Fibronectins - Metabolism
(10)
Extracellular Matrix
(9)
Proteins
(9)
Alternative Splicing
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin

Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer

The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1

Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin

Differentiation between High- and Low-Grade Astrocytoma Using a Human Recombinant Antibody to the Extra Domain-B of Fibronectin

Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8

Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report

Use of Uteroglobin for the Engineering of Polyvalent, Polyspecific Fusion Proteins

Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody

Age, origin and geodynamic significance of plagiogranites in lherzolites and gabbros of the Piedmont-Ligurian ocean basin

mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma

Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder

A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature in vivo

Identification of a novel cell binding site of periostin involved in tumour growth

Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma

Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues

Therapy‐induced antitumor vaccination in neuroblastomas by the combined targeting of IL‐2 and TNFα

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

Selective targeted delivery of TNFα to tumor blood vessels

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor α

The Alternative Splicing Pattern of the Tenascin-C Pre-mRNA Is Controlled by the Extracellular pH (∗)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels

Vandetanib Improves Anti-Tumor Effects of L19mTNFα in Xenograft Models of Esophageal Cancer

A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis‐associated extra type III domain B

comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies

Suchergebnisse filtern